Business Description
Implanet SA
ISIN : US45321V1089
Share Class Description:
IMPZY: ADRCompare
Compare
Traded in other countries / regions
ALIMP.FranceIM11.GermanyIMPZY.USA IPO Date
2016-02-08Description
Implanet SA designs produce and sell medical implants and devices used in orthopedic surgery. Its products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws, and anchors. The company operates in a single segment - the commercialization of orthopedic implants. It derives most of its geographical revenue from France.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -0.02 | |||||
| Debt-to-Equity | -35.36 | |||||
| Debt-to-EBITDA | -1.12 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.73 | |||||
| Beneish M-Score | -5.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -53.7 | |||||
| 3-Year EBITDA Growth Rate | 40.1 | |||||
| 3-Year EPS without NRI Growth Rate | 52.3 | |||||
| 3-Year FCF Growth Rate | 62.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.71 | |||||
| Quick Ratio | 0.29 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 405.2 | |||||
| Days Sales Outstanding | 91.56 | |||||
| Days Payable | 328.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -97.3 | |||||
| Shareholder Yield % | -13.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.84 | |||||
| Operating Margin % | -59.73 | |||||
| Net Margin % | -89.65 | |||||
| FCF Margin % | -29.14 | |||||
| ROE % | -262.15 | |||||
| ROA % | -50.45 | |||||
| ROIC % | -44.38 | |||||
| 3-Year ROIIC % | 120.6 | |||||
| ROC (Joel Greenblatt) % | -214.24 | |||||
| ROCE % | -125.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.54 | |||||
| EV-to-EBIT | -2.97 | |||||
| EV-to-EBITDA | -3.46 | |||||
| EV-to-Revenue | 2.55 | |||||
| EV-to-FCF | -8.79 | |||||
| Price-to-Median-PS-Value | 1 | |||||
| Earnings Yield (Greenblatt) % | -33.67 | |||||
| FCF Yield % | -16.5 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers